Patents by Inventor Mark W. Hermonat

Mark W. Hermonat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4803227
    Abstract: The use of (a) N,N-dialkyl-2-[(4-phenylmethyl)phenoxy]ethanamine and N-morpholino-2-[(4-phenylmethyl)phenoxy]ethanamine compounds and their salts, as anticancer agents, is described. These compounds bind significantly to the anti-estrogen binding sites but only poorly to the estrogen receptor sites, and are cytotoxic to cancer cells. Compositions including mixtures of these ethanamine compounds (a) with (b) therapeutically active anticancer compounds such as tamoxifen, have been found particularly beneficial.
    Type: Grant
    Filed: July 6, 1987
    Date of Patent: February 7, 1989
    Assignee: The University of Manitoba
    Inventors: Lorne J. Brandes, Mark W. Hermonat